Table 1 Inclusion and exclusion criteria for patients with refractory neurogenic lower urinary tract dysfunction (LUTD)
Inclusion criteria | Exclusion criteria |
|---|---|
▪ Age >18 years | ▪ Age <18 years |
▪ Refractory neurogenic LUTD | ▪ Non-neurogenic LUTD |
▪ Urgency frequency syndrome and/or urgency incontinence refractory to antimuscarinics (pharmacotherapy for at least 4 weeks with at least 2 antimuscarinics) | ▪ Botulinum toxin injections into the detrusor and/or urethral sphincter in the last 6 months |
▪ Chronic urinary retention refractory to alpha-blocker (pharmacotherapy with an alpha-blocker for at least 4 weeks) | ▪ Pregnancy or breast feeding |
▪ Combination of urgency frequency syndrome and/or urgency incontinence refractory to antimuscarinics (pharmacotherapy for at least 4 weeks with at least 2 antimuscarinics) and chronic urinary retention refractory to alpha-blocker (pharmacotherapy with an alpha-blocker for at least 4 weeks) | ▪ Individuals especially in need of protection (according to Research with Human Subjects published by the Swiss Academy of Medical Sciences (http://www.samw.ch/en/News/News.html)) |
▪ Written informed consent | ▪ No written informed consent |